Detection of the major urinary metabolite of prostaglandin D2 in the circulation: demonstration of elevated levels in patients with disorders of systemic mast cell activation. Awad JA, Morrow JD, Roberts LJ (1994) J Allergy Clin Immunol 93: 817-24 Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. Morrow JD, Awad JA, Oates JA, Roberts LJ (1992) J Invest Dermatol 98: 812-5 Long-term efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in hyperlipidaemic patients with diabetes or metabolic syndrome. Fazio S, Guyton JR, Lin J, Tomassini JE, Shah A, Tershakovec AM (2010) Diabetes Obes Metab 12: 983-93 Evaluation of effects of unmodified niacin on fasting and postprandial plasma lipids in normolipidemic men with hypoalphalipoproteinemia. King JM, Crouse JR, Terry JG, Morgan TM, Spray BJ, Miller NE (1994) Am J Med 97: 323-31 Nonpharmacologic treatment of dyslipidemia. Houston MC, Fazio S, Chilton FH, Wise DE, Jones KB, Barringer TA, Bramlet DA (2009) Prog Cardiovasc Dis 52: 61-94 Race and gender variation in response to evoked inflammation. Ferguson JF, Patel PN, Shah RY, Mulvey CK, Gadi R, Nijjar PS, Usman HM, Mehta NN, Shah R, Master SR, Propert KJ, Reilly MP (2013) J Transl Med 11: 63 Long-term safety and efficacy of triple combination ezetimibe/simvastatin plus extended-release niacin in patients with hyperlipidemia. Fazio S, Guyton JR, Polis AB, Adewale AJ, Tomassini JE, Ryan NW, Tershakovec AM (2010) Am J Cardiol 105: 487-94 Psychoses and creativity: is the missing link a biological mechanism related to phospholipids turnover? Folley BS, Doop ML, Park S (2003) Prostaglandins Leukot Essent Fatty Acids 69: 467-76
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.